VEGFB and diabetes mellitus: This approach has been successfully employed in diabetes and obesity treatments.[24, 25] We used surface plasmon resonance (SPR) technology to study the binding interaction between VEGF‐B and NRP1 and to measure the direct binding affinity and kinetics between the novel peptides and NRP1.